0

Generating evidence for optimal market access – an Executive Interview with Jeff Anderson and Rosemary Jose, OPEN Health

Jeff Anderson is CEO of the Evidence & Access practice and Rosemary Jose leads Strategic Market Access strategy and activities. They talk about current dynamics in the healthcare industry and the challenges of generating evidence for optimal market access. Continue Reading

0

Using AI, NLP and Data Visualization with RWE to Generate Insights into Care Gaps: Retrospective Cohort Analysis of Fracture Risk in Patients with Osteopenia and Osteoporosis

This blog reports practical uses of RWD sourced from the largest, cloud-based electronic health record (EHR) platform in the United States, offered by Veradigm® as part of its Health Insights database. Continue Reading

0

Addressing a Prominent Health Burden Using Real World Evidence: Management of Heart Failure with Preserved Ejection Fraction

Heart Failure: Common, Debilitating and Growing Public Health Issue Heart failure (HF) is a complex, debilitating syndrome affecting an estimated 63 million people worldwide (GBD 2016). Its impact on patients and health systems continues to increase in tandem with rising… Continue Reading

0

Predictive Modeling and Machine Learning: Sharpening the Focus of Real-World Evidence in the Age of Precision Medicine

The challenge of real-world evidence in the age of precision medicine Real-world evidence is being used increasingly to provide important information about natural history of a disease, drug utilization and treatment patterns, comorbidities, safety and effectiveness of medications, along with… Continue Reading

0

Tackling Rare Diseases with an Arsenal of Real-World Data

Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and other high-value subphenotypes. Continue Reading